STOCK TITAN

ASLAN Pharmaceuticals Ltd - ASLN STOCK NEWS

Welcome to our dedicated news page for ASLAN Pharmaceuticals (Ticker: ASLN), a resource for investors and traders seeking the latest updates and insights on ASLAN Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ASLAN Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ASLAN Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.03%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.31%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.57%
Tags
clinical trial
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20.83%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.39%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
earnings
ASLAN Pharmaceuticals Ltd

Nasdaq:ASLN

ASLN Rankings

ASLN Stock Data

10.83M
370.17M
0.05%
14.9%
1.65%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Cayman Islands
190 Elgin Avenue

About ASLN

aslan pharmaceuticals (aslan, 6497.tt) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. aslan targets diseases that are both highly prevalent in asia and orphan indications in the united states and europe. led by a senior management team with extensive experience in global and regional development and commercialization, aslan is headquartered in singapore and has offices in taiwan and china. aslan’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. aslan’s partners include array biopharma, bristol-myers squibb, almirall and csl.